Brexit: Doctors’ first duty in no-deal planning is to speak up about the risks to patients
Doctors have a duty to tell the public if a policy puts them at risk […]
Doctors have a duty to tell the public if a policy puts them at risk […]
To maintain efficiency in medical research we have to facilitate and empower participants, patients, and the public to recognise waste and take action, say Virginia Minogue and Bill Wells […]
From time to time someone writes asking me to explain some aspect of punctuation. Recently I have been asked to arbitrate between “sub-group” and “subgroup”. I prefer the latter. The […]
Giles Maskell takes a satirical look at providing feedback for doctors […]
As the NHS explores the potential impact of AI on healthcare provision we should be wary of the revolving door between Big Tech companies and the NHS, says Paul Tiffin […]
Last week I suggested that many terms, such as “biological markers”, “surrogate markers”, “intermediate markers”, “surrogate response variables”, “surrogate endpoints”, “intermediate endpoints”, “biomarker endpoints”, and “intermediate marker endpoints”, could be […]
Many clinical outcomes, both primary and secondary, which I discussed two weeks ago, are not the desired outcomes, but markers of such—surrogate markers or biomarkers. The term “biomarker” comes from […]
Lord Prior, the chair of NHS England, is tall and thin, has a playful smile most of the time, and answers questions with a directness unusual in the higher echelons […]
Not a day goes by without the transvaginal mesh story evolving and becoming more confusing. The issues are complex, and it is often difficult to know what is being recommended […]
While my contribution to this section of The BMJ was being published last week, I was in Manchester, at a festschrift for my colleague Brian Houston, marking his retirement, on […]